Loading…
Cabot Corporation is projected to rise to $118.62 by 2027, a +36% move from its current price of $87.32. CBT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $85.48 | $87.39 | $89.34 | +0.08% |
| Jul 13 | $84.78 | $87.46 | $90.23 | +0.16% |
| Jul 14 | $84.25 | $87.53 | $90.94 | +0.24% |
| Jul 15 | $83.82 | $87.60 | $91.56 | +0.33% |
| Jul 16 | $83.46 | $87.68 | $92.11 | +0.41% |
| Jul 17 | $83.13 | $87.75 | $92.62 | +0.49% |
| Jul 18 | $82.84 | $87.82 | $93.10 | +0.57% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $82.84 | $87.82 | $93.10 | +0.57% |
| Week 2 | $81.32 | $88.32 | $95.92 | +1.14% |
| Week 3 | $80.28 | $88.82 | $98.27 | +1.72% |
| Week 4 | $79.49 | $89.33 | $100.39 | +2.30% |
| Week 5 | $78.85 | $89.84 | $102.37 | +2.89% |
| Week 6 | $78.32 | $90.35 | $104.24 | +3.47% |
| Week 7 | $77.87 | $90.87 | $106.04 | +4.06% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through two segments, Reinforcement Materials and Performance Chemicals.
The company offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
It also provides specialty carbons for use in inks, coatings, plastics, adhesives, toners, batteries, and displays; conductive additives and fumed alumina used in lead acid and lithium-ion batteries for electric vehicles; fumed silica used in adhesives, sealants, cosmetics, batteries, inks, toners, silicone elastomers, coatings, polishing slurries, and pharmaceuticals; and fumed alumina for use in various products, including inkjet media, lighting, coatings, cosmetics, and polishing slurries. In addition, it offers aerogel, a hydrophobic, silica-based particle to use in various thermal insulation and specialty chemical applications; masterbatch and conductive compound products that are used in automotive, industrial, packaging, infrastructure, agriculture, consumer products, and electronics industries; and inkjet colorants for inkjet printing applications, as well as carbon nanotubes and fumed metal oxides.
The company sells its products through distributors and sales representatives in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cabot Corporation was founded in 1882 and is headquartered in Boston, Massachusetts.
Cabot Corporation (CBT) is a Basic Materials company with a current price of $82.90 and a market capitalization of $4.28B. It ranks 1486.
The long-range forecast shows a bullish trajectory, with the average price rising from 2027 onward: 2027 avg 111.26, 2028 avg 116.91, 2029 avg 134.31, and 2030 avg 141.33.
Further out, the forecast indicates 2040 avg 359.91 and 2050 avg 684.96, with max values reaching as high as 1,175.30. These figures illustrate substantial upside over time, even as near-term estimates vary and 2026 remains neutral in the sequence.
Overall, the outlook is bullish across the longer horizon, with increasing averages and upside potential suggesting meaningful price advancement over the coming years, while recognizing that these are estimates and not guarantees.
A major floor 22.4% below — a decisive break under it would weaken the trend.
The nearest floor, 7.4% below — buyers have tended to step in here.
The nearest ceiling, 7.0% above — a clean break opens room to run.
A major ceiling 14.2% above — clearing it would confirm fresh momentum.
Key CBT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CBT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $86.15 | Buy | $86.46 | Buy |
| MA 10 | $87.84 | Sell | $87.18 | Buy |
| MA 20 | $88.62 | Sell | $87.32 | Buy |
| MA 50 | $84.84 | Buy | $84.71 | Buy |
| MA 100 | $79.18 | Buy | $80.96 | Buy |
| MA 200 | $74.09 | Buy | $78.39 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.95 | Neutral |
| Stoch RSI (14) | 40.20 | Neutral |
| CCI (20) | -38.91 | Neutral |
| Williams %R (14) | -57.90 | Info |
| MACD (12,26,9) | -0.78 | Sell |
| ROC (12) | -0.19 | Sell |
| Bollinger %B (20,2) | 0.38 | Neutral |
| Stochastic %K (14) | 42.10 | Neutral |
| TRIX (15) | 0.21 | Buy |
| Awesome (5,34) | -0.73 | Sell |
| Ultimate (7,14,28) | 40.99 | Neutral |
| Momentum (10) | -5.77 | Sell |
| Aroon Osc (25) | 56.00 | Buy |
| Hull MA (9) | 84.68 | Buy |
| ADX (14) | 14.41 | Neutral |
| ATR (14) | 1.88 | Info |
The 30-day technical picture is bullish.
RSI14 is 40, and the moving averages show SMA50 at $84.46 and SMA200 at $74.00. Support is $80.88 and resistance is $93.40. The 30-day price range spans from $71.69 to $95.87.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $67.05 | $87.32 | $121.94 | 0% | Neutral | |
| $96.11 | $118.62 | $153.80 | +36% | Bullish | |
| $99.42 | $125.44 | $167.70 | +44% | Bullish | |
| $112.75 | $144.87 | $198.42 | +66% | Bullish | |
| $117.92 | $153.96 | $215.22 | +76% | Bullish | |
| $121.65 | $161.14 | $229.32 | +85% | Bullish | |
| $147.60 | $198.17 | $286.58 | +127% | Bullish | |
| $169.11 | $229.93 | $337.40 | +163% | Bullish | |
| $181.41 | $249.60 | $371.25 | +186% | Bullish | |
| $188.19 | $261.89 | $394.43 | +200% | Bullish | |
| $278.55 | $407.94 | $647.74 | +367% | Bullish | |
| $495.08 | $790.07 | $1,355.98 | +805% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $67.05 | $87.32 | $103.58 | +0.00% |
| August 2026 | $76.38 | $89.70 | $107.84 | +2.72% |
| September 2026 | $79.63 | $94.04 | $114.09 | +4.84% |
| October 2026 | $80.58 | $95.63 | $116.90 | +1.69% |
| November 2026 | $80.40 | $95.80 | $117.87 | +0.18% |
| December 2026 | $82.38 | $98.54 | $121.94 | +2.85% |
Click any year to see its month-by-month CBT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect CBT to range from $67.05 to $121.94 through 2026. The $87.32 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The CBT price prediction for 2027 points to an average of $118.62 (low $96.11, high $153.80) — a potential gain of +36% on today's $87.32. Buyers look set to stay in control over this stretch.
In 2028, CBT is projected to trade between $99.42 and $167.70, averaging $125.44 — a potential gain of +44% from today's $87.32. That is up +6% on the projected 2027 average. Momentum favours further upside here.
Cabot Corporation's 2029 outlook centres on $144.87, within a $112.75 to $198.42 range. That is up +15% on the projected 2028 average. That marks a +66% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, CBT could reach as high as $215.22, with a base case around $153.96 and support toward $117.92 — roughly +76% from $87.32. Momentum favours further upside here.
Expect CBT to range from $121.65 to $229.32 through 2031. The $161.14 average target implies a +85% move from current prices. That is up +5% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The CBT price prediction for 2032 points to an average of $198.17 (low $147.60, high $286.58) — a potential gain of +127% on today's $87.32. Momentum favours further upside here.
In 2033, CBT is projected to trade between $169.11 and $337.40, averaging $229.93 — a potential gain of +163% from today's $87.32. That is up +16% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Cabot Corporation's 2034 outlook centres on $249.60, within a $181.41 to $371.25 range. That is up +9% on the projected 2033 average. That marks a +186% change versus current levels. Momentum favours further upside here.
By 2035, CBT could reach as high as $394.43, with a base case around $261.89 and support toward $188.19 — roughly +200% from $87.32. Buyers look set to stay in control over this stretch.
Expect CBT to range from $278.55 to $647.74 through 2040. The $407.94 average target implies a +367% move from current prices. That is up +56% on the projected 2035 average. Momentum favours further upside here.
The CBT price prediction for 2050 points to an average of $790.07 (low $495.08, high $1,355.98) — a potential gain of +805% on today's $87.32. Buyers look set to stay in control over this stretch.
Investing $1,000 in CBT today (≈ 11.45213 CBT) could be worth
$9,048.02
+$8,048.02 (+805%) by 2050 · US Dollar
Based on the average projected CBT price of $790.07 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CBTwould be worth at today's price.
$1,000 invested in CBT on Jul 10, 2025 (≈ 12.648622 CBT) would be worth
$1,104.48
+$104.48 (+10.4%) today · 1.10× · US Dollar
Based on a CBT entry price of $79.06 vs. today's $87.32.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $86.35 | $1,011.23 | +1.1% |
| 1 month ago | $83.03 | $1,051.67 | +5.2% |
| 3 months ago | $74.62 | $1,170.2 | +17.0% |
| 6 months ago | $73.05 | $1,195.35 | +19.5% |
| 1 year ago | $79.06 | $1,104.48 | +10.4% |
| All time (5.0y) ago | $58.79 | $1,485.29 | +48.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CBT forecast.
Our base-case forecast reaches $170.00 around 2032.
Implied market cap at $170.00: $8.78B
The multi-year forecast outlines a bullish trajectory with rising averages and higher ROI deeper into the horizon. Key milestones include 2027 avg 111.26, 2028 avg 116.91, 2029 avg 134.31, and 2030 avg 141.33, reflecting a steady acceleration in expected value.
By 2040, the forecast shows an avg of 359.91 and by 2050 an avg of 684.96, with corresponding max values up to 571.37 in 2040 and 1,175.30 in 2050. The ROI figures rise correspondingly, reaching 70.5 in 2030, 334.1 in 2040, and 726.3 by 2050, with sentiment remaining BULLISH in the later years.
These projections illustrate a sustained upside path, but they are estimates and not guarantees. Investors should consider that outcomes will depend on market conditions and other factors not captured by the forecast.
Tap a question to reveal the answer.
Avg 141.33; min 108.25; max 197.55; ROI 70.5; sentiment BULLISH.
Yes. The outlook becomes bullish from 2027 onward, with averages rising from 111.26 in 2027 to 684.96 in 2050, and ROI rising to 726.3 by 2050.
Yes. The max values indicate prices above 230, with 2032 max 259.51, 2033 max 304.07, 2034 max 333.41, and 2035 max 353.77.
Current price $82.90; market cap $4.28B.
Avg 684.96; min 429.34; max 1,175.30; ROI 726.3; sentiment BULLISH.
Cabot Corporation Community Discussion
0Share your Cabot Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.